clinical trial · NCT06139393
Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
Jiangsu HengRui Medicine Co., Ltd.·phase3·completed·n = 765
Gout With Hyperuricemia in AdultsHR091506 tablets + placebo of febuxostat tabletsfebuxostat tablets + placebo of HR091506 tablets
brief summary
The study is being conducted to evaluate the efficacy, and safety of HR091506 tablets for treatment of gout with hyperuricemia in adults, and to compare the results with febuxostat tablets in the same doses.
started
Dec 14, 2023
primary completion
Aug 18, 2025
completion
Sep 4, 2025
last updated
Oct 2, 2025
official title
Study on Efficacy and Safety of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol